Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Biologics : Targets & Therapy|December 24, 2016
Centrosome - a promising anti-cancer targetYainyrette Rivera-Rivera, Harold I SaavedraExperimental Biology and Medicine (Maywood, N.J.)|February 19, 2021
Mitotic kinases as drivers of the epithelial-to-mesenchymal transition and as therapeutic targets against breast cancersStephanie Colón-Marrero, Shirley Jusino, Yainyrette Rivera-Rivera, et al.Oncotarget|November 5, 2017
The E2F activators control multiple mitotic regulators and maintain genomic integrity through Sgo1 and BubR1Miyoung Lee, Yainyrette Rivera-Rivera, Carlos S Moreno, et al.Journal of Clinical & Cellular Immunology|February 13, 2015
Depression Correlates with Increased Plasma Levels of Inflammatory Cytokines and a Dysregulated Oxidant/Antioxidant Balance in HIV-1-Infected Subjects Undergoing Antiretroviral TherapyYainyrette Rivera-Rivera, Yashira García, Valerie Toro, et al.Journal of Clinical & Cellular Immunology|August 2, 2016
Impact of Depression and Inflammation on the Progression of HIV DiseaseYainyrette Rivera-Rivera, Fabián J Vázquez-Santiago, Elinette Albino, et al.Biochimica Et Biophysica Acta. Molecular Cell Research|December 14, 2020
Tank Binding Kinase 1 modulates spindle assembly checkpoint components to regulate mitosis in breast and lung cancer cellsMeenu Maan, Neha Jaiswal Agrawal, Jaya Padmanabhan, et al.Scientific Reports|April 28, 2021
The Nek2 centrosome-mitotic kinase contributes to the mesenchymal state, cell invasion, and migration of triple-negative breast cancer cellsYainyrette Rivera-Rivera, Mihaela Marina, Shirley Jusino, et al.Cell Division|April 30, 2023
Sustained Shugoshin 1 downregulation reduces tumor growth and metastasis in a mouse xenograft tumor model of triple-negative breast cancerShirley Jusino, Yainyrette Rivera-Rivera, Camille Chardón-Colón, et al.Cell Division|December 10, 2022
Ethnic and racial-specific differences in levels of centrosome-associated mitotic kinases, proliferative and epithelial-to-mesenchymal markers in breast cancersYainyrette Rivera-Rivera, Geraldine Vargas, Neha Jaiswal, et al.Experimental Biology and Medicine (Maywood, N.J.)|August 9, 2021
E2F3 drives the epithelial-to-mesenchymal transition, cell invasion, and metastasis in breast cancerShirley Jusino, Yainyrette Rivera-Rivera, Camille Chardón-Colón, et al.Pageof 1